Código QR (código de barras bidimensional)

Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Outflows in Type 2 Diabetes

Background: Sodium glucose co-transporter type 2 inhibitors improve cardiovascular outcomes in people with type 2 diabetes, though mechanisms by which this occurs remain unclear. Objectives: The purpose of this study was to evaluate empagliflozin’s effect on whole body, cardiac, and renal sympatheti...

ver descrição completa

Na minha lista:
Principais autores: Anne T. Reutens, MBBS, PhD, FRACP, Dulari Hakamuwa Lekamlage, PhD, Agus Salim, PhD, Jonathan E. Shaw, MBChB, MD, FRCP (UK), FRACP, FAAHMS, Murray D. Esler, MBBS, PhD, FRACP, Mark E. Cooper, MBBS, PhD, David M. Kaye, MBBS, PhD, FRACP
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2025-12-01
coleção:JACC: Advances
Assuntos:
empagliflozin
hemodynamics
norepinephrine spillover kinetics right heart catheter
SGLT2 inhibitor
sympathetic nervous activity
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2772963X25007331
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados